release time:2023-08-11 14:45:36
Biochemistry analyzers are the unsung heroes of modern healthcare, facilitating rapid and accurate diagnoses that are crucial for patient care. In this comprehensive exploration, we shed light on the top 9 Chinese biochemistry analyzer manufacturers, delving into their innovations and significant contributions to the advancement of healthcare diagnostics.
Nestled in the heart of technological innovation, Chengdu Seamaty Technology Co., Ltd. has been a driving force in the field of Point-of-Care Testing (POCT) since its inception in 2012. With a commitment to revolutionizing medical diagnostics, Seamaty has carved a niche for itself as a high-tech enterprise specializing in biochemistry analyzers that deliver rapid and precise results.
The company's dedication to quality is underscored by its ISO 13485:2016 international quality management system certification. Seamaty's production facility boasts three fully automated production lines, bolstered by a vigilant quality control team that ensures not only high productivity but also unwavering product excellence.
Seamaty's innovation extends beyond its production lines, as evidenced by its research centers strategically located in Chengdu and Shenzhen. These centers serve as crucibles of cutting-edge technological advancements in the realm of in-vitro diagnostics, contributing to the evolution of diagnostic practices.
To further fortify its global presence, Seamaty has established overseas subsidiaries in countries such as Germany, Russia, and Thailand. This international reach positions Seamaty as a formidable contender in the global biochemistry analyzer market, reflecting its commitment to providing state-of-the-art diagnostic solutions that transcend borders.
Seamaty is particularly focused on the development of dry biochemistry analyzers, whose products are characterized by small and portable size, fast testing, and accurate results. Seamaty offers two primary categories of biochemistry products: biochemistry analyzers for humans and for veterinary use, such as the SD1 Biochemistry Analyzer, SMT-120 Biochemistry Analyzer, Semi-auto Biochemistry Analyzer, and SMT-120VP Veterinary Biochemistry Analyzer.
Founded in 1991, Mindray, a household name in the medical device arena, stands as a beacon of advancement in medical diagnostics. With a rich history of innovation, Mindray's biochemistry analyzers exemplify its dedication to precision and efficiency. These analyzers equip healthcare professionals with a potent toolset, offering real-time insights for a wide array of biochemical parameters. From routine clinical chemistry tests to intricate diagnostic analyses, Mindray's biochemistry analyzers empower medical practitioners to make informed decisions swiftly and effectively.
Beyond the confines of the laboratory, Mindray's impact is felt on a global scale. Its commitment to elevating healthcare standards transcends geographic boundaries, bringing accessible and accurate diagnostics to diverse populations. Mindray provides biochemical analyzer products with different testing volumes: large, medium and small. The famous products are BS-series, such as BS-2000, BS-600 and BS-480.
Perlong Medical Equipment Co., Ltd., was founded in 2003, headquartered in Nanjing, which is an industry leader with a focus on laboratory equipment, has significantly contributed to the field of biochemistry analyzers. With a rich history of excellence, the company's dedication to innovation and quality underscores its impactful role in healthcare diagnostics. Perlong Medical's biochemistry analyzers embody the company's ethos, delivering reliable and precise results that aid healthcare professionals in making informed decisions.
The company's commitment to research and development ensures that its biochemistry analyzers remain at the forefront of technological advancements. Through continuous innovation, Perlong Medical continues to redefine the boundaries of laboratory equipment, enhancing the capabilities of medical practitioners and enabling swifter, more accurate diagnoses. Their biochemistry analyzer products include two types: fully automatic and semi-automatic, such as BA-220 and BA-733+.
Since its foundation in 1981, Shanghai Kehua Bio-Engineering Co., Ltd. (KHB) stands as a pioneering force in the realm of bio-engineering. With a legacy rooted in technological excellence, KHB has established itself as a reliable source of innovative in-vitro diagnostic solutions, prominently featuring biochemistry analyzers.
KHB's journey has been marked by milestones that have redefined the landscape of diagnostics. By leveraging cutting-edge technologies, the company's biochemistry analyzers provide accurate and timely results that aid healthcare professionals in making critical decisions. KHB's contributions extend beyond diagnostics; they are instrumental in shaping the trajectory of healthcare by providing tools that empower medical practitioners to deliver quality care. The main biochemistry analyzer products of KHB are Polaris-series, such as Polaris c1000 which can run 1000 tests per hour.
Changchun DIRUI Medical starts as a urine strips manufacturer in 1992, with continuous research and development, now the product portfolio are covering biochemistry, urinalysis, hematology, chemiluminescence immunoassay, gynecology, blood coagulation analysis, molecular diagnostics and integrated laboratory 8 product lines. DIRUI specializes in clinical chemistry, offering state-of-the-art biochemistry analyzers that enhance diagnostic accuracy. Their biochemistry analyzer products are CS-series, such as CS-2000 and CS-480.
Founded in 1992, Guangzhou Wondfo Biotech excels in biotechnology, delivering diagnostic solutions that impact both human and veterinary diagnostics. Wondfo now has more than 3000 employees and a wide range of products for the rapid identification of cardiovascular diseases, inflammation, tumor, infectious diseases, drug abuse, pregnancy, and so on, widely sold to 140+ countries and regions. This company is doing well in products based on fluorescence immunoassay.
BIOBASE is a new high-tech enterprise whose business covers biomedical, e-commerce, intelligent manufacturing, scientific equipment, In Vitro Diagnosis (IVD) instrument and reagent. BIOBASE is specialized in medical equipment and laboratory equipment products, with more than 200 existing high-tech products. Their biochemistry analyzer products are BK-Series, such as BK-200 and BK-1200.
URIT Medical Electronic Group's diagnostic products contribute to medical diagnostics, with a focus on improving clinical laboratory capabilities. Their biochemistry analyzer products are CA-series and URIT-series.
BPC BioSed SRL is a family company created in 1986 as scientific instruments importer. In 1991, BPC BioSed launched its first analyser, especially developed for medium laboratories. It excels in sedimentation analysis, contributing to biochemistry analyzers and precise clinical diagnostics. Their biochemistry analyzer products are KENYA-series, such as KENZA ONE.
Conclusion
In the realm of modern medicine, the top 9 Chinese biochemistry analyzer manufacturers are architects of healthcare's future. From Seamaty's POCT excellence to Mindray's global impact, Perlong Medical's solutions, and KHB's pioneering bio-engineering, they redefine diagnostics. These four are just the beginning. DIRUI's chemistry excellence, Wondfo's biotech innovations, Biobase's labs, URIT Medical's solutions, and BPC BioSed's precision diagnostics complete this transformative story. Together, these manufacturers drive innovation, collaboration, and progress in healthcare. They light the path to quicker diagnoses, informed decisions, and better patient outcomes. The future of healthcare is in their hands – the hands that build the analyzers guiding us forward.
2022-03-09
Numerous animal hospitals and animal diagnostic centers are equipped with vet biochemistry analyzer machines, which are used to do routine blood tests on pets/animals in order to diagnose disease more quickly and precisely.
2021-11-22
Common sample abnormalities in clinical laboratory medicine include hemolysis, lipemia and jaundice, and of course veterinary clinics are no exception. The overindulgence of pets has led to an imbalance in food intake, resulting in an increase in the number of pets with hyperlipidemia. Also, many of the pets that require biochemical testing are emergency cases. They do not undergo a 12-hour food evacuation period. Others undergo biochemical testing after intravenous injection of fat milk. These are some of the conditions that lead to an increased likelihood of lipemia in pet samples. Here we will learn more about lipemia samples.
2021-10-26
Diet affects a variety of substances in the blood. For example, the concentrations of glucose (GLU), triacylglycerol (TG), ALP and phosphorus. Eating a high-protein diet one day before the blood draw can result in high urea nitrogen (BUN) and uric acid (UA) results. The increase in lipid concentrations in the blood, especially TG, after eating can lead to a milky cloudy serum, which can interfere with biochemical measurements. This may result in high results for bile acids, proteins, calcium and phosphorus. The results of amylase measurements are low.
